Skip to main content

Advertisement

SpringerLink
Log in

The Need for an Integrated Patient Navigation Pathway to Improve Access to Colonoscopy After Positive Fecal Immunochemical Testing: A Safety-Net Hospital Experience

  • Original Paper
  • Published:
Journal of Community Health Aims and scope Submit manuscript

Abstract

Colorectal cancer (CRC) is a leading cause of cancer-related deaths in the United States. Delays in access to colonoscopy following positive fecal immunochemical test (FIT) contribute to increased CRC incidence and mortality. To evaluate intervals from positive FIT result to receipt of colonoscopy among underserved safety-net populations. We retrospectively evaluated all average CRC risk adults who had positive FIT results from 2012 to 2015 at an ethnically diverse safety-net hospital system. Interval from positive FIT to receipt of colonoscopy was evaluated with Kaplan Meier methods and multivariate Cox proportional hazards models. Among 467 patients with positive FIT (48.4 % men, 39.5 % black, 22.5 % white, 17.4 % Asian, 9.7 % Hispanic, mean age 59.5 ± 9.8 years), mean time from positive FIT to receipt of colonoscopy was 220.5 days (SD 158.5). Compared to men, there was a trend towards longer time from FIT positive to colonoscopy among women (237.1 vs. 198.7 days, p = 0.07). No race/ethnicity-specific disparities in time to colonoscopy were observed. Compared to 2012–2013, there was a 27.2 % reduction in time from FIT positive to colonoscopy in 2014–2015 (173.9 vs. 238.8 days, p < 0.01). Among patients undergoing colonoscopy, 46.3 % had adenomatous polyps, 27.4 % had high risk adenomatous polyps, and 5.6 % had CRC. Among an ethnically diverse safety-net hospital system, improvements in access to colonoscopy after positive FIT were observed. However, patients still waited nearly 6 months from time of positive FIT to undergoing colonoscopy. Delays in receipt of colonoscopy are complex and reflect system-level and individual patient-level barriers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Siegel, R. L., Miller, K. D., & Jemal, A. (2016). Cancer statistics, 2016. CA: A Cancer Journal for Clinicians, 66(1), 7–30. doi:10.3322/caac.21332.

    Google Scholar 

  2. Amri R, Bordeianou LG, Sylla P, Berger DL. (2013). Impact of screening colonoscopy on outcomes in colon cancer surgery. JAMA Surgery, 148(8), 747–754. doi:10.1001/jamasurg.2013.8.

    Article  PubMed  Google Scholar 

  3. FORCE USPST, Bibbins-Domingo, K., Grossman, D. C., et al. (2016). Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA, 315(23), 2564–2575. doi:10.1001/jama.2016.5989.

    Article  Google Scholar 

  4. Knudsen AB, Zauber AG, Rutter CM, et al. (2016). Estimation of benefits, burden, and harms of colorectal cancer screening strategies: Modeling study for the US preventive services task force. JAMA, 315(23), 2595–2609. doi:10.1001/jama.2016.6828.

    Article  CAS  PubMed  Google Scholar 

  5. FORCE USPST (2008). Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 149(9), 627–637.

    Article  Google Scholar 

  6. Meester RG, Zauber AG, Doubeni CA, et al. (2016). Consequences of increasing time to colonoscopy examination following positive result from fecal colorectal cancer screening test. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association. doi:10.1016/j.cgh.2016.05.017.

    Google Scholar 

  7. Chubak J, Garcia MP, Burnett-Hartman AN, et al. (2016). Time to colonoscopy after positive fecal blood test in four U.S. Health Care Systems. Cancer epidemiology, biomarkers & prevention: A publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 25(2), 344–350. doi:10.1158/1055-9965.EPI-15-0470.

    Google Scholar 

  8. Gellad ZF, Almirall D, Provenzale D, Fisher DA. (2009). Time from positive screening fecal occult blood test to colonoscopy and risk of neoplasia. Digestive Diseases and Sciences, 54(11), 2497–2502. doi:10.1007/s10620-008-0653-8.

    Article  PubMed  Google Scholar 

  9. Oluloro A, Petrik AF, Turner A, et al. (2016). Timeliness of colonoscopy after abnormal fecal test results in a safety net practice. Journal of Community Health, 41(4):864–870. doi:10.1007/s10900-016-0165-y.

    Article  PubMed  Google Scholar 

  10. Millas, S. G., Alawadi, Z. M., Wray, C. J., et al. (2015). Treatment delays of colon cancer in a safety-net hospital system. The Journal of Surgical Research, 198(2), 311–316. doi:10.1016/j.jss.2015.03.078.

    Article  PubMed  Google Scholar 

  11. Lumpkins, C., Cupertino, P., Young, K., Daley, C., Yeh, H., & Greiner, K. (2013). Racial/ethnic variations in colorectal cancer screening self-efficacy, fatalism and risk perception in a safety-net clinic population: Implications for tailored interventions. Journal of Community Medicine & Health Education, 3.

  12. Jerant, A. F., Fenton, J. J., & Franks, P. (2008). Determinants of racial/ethnic colorectal cancer screening disparities. Archives of Internal Medicine, 168(12), 1317–1324. doi:10.1001/archinte.168.12.1317.

    Article  PubMed  Google Scholar 

  13. Correia A, Rabeneck L, Baxter NN, et al. (2015). Lack of follow-up colonoscopy after positive FOBT in an organized colorectal cancer screening program is associated with modifiable health care practices. Preventive Medicine, 76, 115–122. doi:10.1016/j.ypmed.2015.03.028.

    Article  PubMed  Google Scholar 

  14. Etzioni, D. A., Yano, E. M., Rubenstein, L. V., et al. (2006). Measuring the quality of colorectal cancer screening: The importance of follow-up. Diseases of the Colon and Rectum, 49(7), 1002–1010. doi:10.1007/s10350-006-0533-2.

    Article  PubMed  Google Scholar 

  15. Powell, A. A., Gravely, A. A., Ordin, D. L., Schlosser, J. E., & Partin, M. R. (2009). Timely follow-up of positive fecal occult blood tests strategies associated with improvement. American Journal of Preventive Medicine, 37(2), 87–93. doi:10.1016/j.amepre.2009.05.013.

    Article  PubMed  Google Scholar 

  16. Ferrat, E., Le Breton, J., Veerabudun, K., et al. (2013). Colorectal cancer screening: Factors associated with colonoscopy after a positive faecal occult blood test. British Journal of Cancer, 109(6), 1437–1444. doi:10.1038/bjc.2013.476.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Gupta S, Halm EA, Rockey DC, et al. (2013). Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: A randomized clinical trial. JAMA Internal Medicine, 173(18), 1725–1732. doi:10.1001/jamainternmed.2013.9294.

    PubMed  PubMed Central  Google Scholar 

  18. Humphrey, L. L., Shannon, J., Partin, M. R., O’Malley, J., Chen, Z., & Helfand, M. (2011). Improving the follow-up of positive hemoccult screening tests: An electronic intervention. Journal of General Internal Medicine, 26(7), 691–697. doi:10.1007/s11606-011-1639-3.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Powell, A. A., Nugent, S., Ordin, D. L., Noorbaloochi, S., & Partin, M. R. (2011). Evaluation of a VHA collaborative to improve follow-up after a positive colorectal cancer screening test. Medical Care, 49(10), 897–903. doi:10.1097/MLR.0b013e3182204944.

    Article  PubMed  Google Scholar 

  20. Singh H, Kadiyala H, Bhagwath G, et al. (2009). Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results. The American Journal of Gastroenterology, 104(4), 942–952. doi:10.1038/ajg.2009.55.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Stock, D., Rabeneck, L., Baxter, N. N., et al. (2015). Mailed participant reminders are associated with improved colonoscopy uptake after a positive FOBT result in Ontario’s ColonCancerCheck program. Implementation Science: IS, 10, 35. doi:10.1186/s13012-015-0226-0.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Gastroenterology and Hepatology, Alameda Health System – Highland Hospital, 1411 East 31st Street, Highland Hospital – Highland Care Pavilion 5th Floor, Oakland, CA, 94602, USA

    Sreedevi Thamarasseril, Taft Bhuket, Chuck Chan, Benny Liu & Robert J. Wong

Authors
  1. Sreedevi Thamarasseril
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Taft Bhuket
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chuck Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Benny Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Robert J. Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert J. Wong.

Ethics declarations

Conflict of Interest

The authors of this manuscript have no conflicts of interest to disclose.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Thamarasseril, S., Bhuket, T., Chan, C. et al. The Need for an Integrated Patient Navigation Pathway to Improve Access to Colonoscopy After Positive Fecal Immunochemical Testing: A Safety-Net Hospital Experience. J Community Health 42, 551–557 (2017). https://doi.org/10.1007/s10900-016-0287-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10900-016-0287-2

Keywords

Search

Navigation